Skip to main content

The international conference Redefining Early Stage Investments (RESI), organized by Life Science Nation (LSN), will take place in Barcelona from April 1 to 3, 2025, with the goal of connecting early-stage startups with international investors to establish strategic alliances. Additionally, it will also be aimed at scaleups, service providers, and tech hubs. This boutique conference, typically held in the United States, will return to Europe and choose Barcelona to host its second edition thanks to the collaboration of Biocat, the City of Barcelona, and the Government of Catalonia.

The event will bring together over 250 investors specializing in seed, Series A, and Series B stages, and will focus on sectors such as drug development, medical devices, diagnostics, and digital health. The first day of the conference will be held in person and will include partnering sessions and activities like the Healthtech Market Access Panel, organized by Biocat. The following two days will be held virtually, with spaces for pitches, workshops, and keynote conferences in the sector.

Register

A unique and different conference in Europe

  • It is the only event with a 1:1 ratio of investors to startups. RESI EUROPE Barcelona will bring between 250 and 300 international investors. These investors are part of an international network and are looking for seed, Series A, and Series B opportunities. 
  • It is an event dedicated to global investors and licensing partners in the pharmaceutical, medical devices, diagnostics, and digital health sectors. 
  • Roundtables and workshops: learn about the latest market trends, investment strategies, and best business practices. 
  • The Innovators Pitch Challenge (IPC) guarantees that a startup can present itself to a panel of investors that align with its development stage and product. Each participant will receive written feedback from the investor. 
  • Networking: RESI is not only a platform for exchanging investment opportunities but also a space for collaboration and innovation. Create new synergies and strategic alliances with other stakeholders through the partnering platform. 
  • Sponsorship package: multiple benefits to increase visibility and connections during the conference.

Discounts for entities of the BioRegion

The alliance to bring the international conference Redefining Early Stage Investments (RESI) to Barcelona in 2025 will offer, once again, exclusive benefits for organizations in the BioRegion of Catalonia.

BioRegion companies

& organizations

3 Days2 DaysAcces Pass
Dicount codesBIOCAT3DAYBIOCAT2DAYBIOCATAAP

Earlybird

Until February 28th

895 €395 €300 €
Standard995 €545 €445 €

 


Preparation Webinar Series (open to the public)
 

IPC Package (Innovator’s Pitch Challenge)

Startups from the BioRegion participating in IPC 2025

Complimentary Educational Program included for the 15 IPC selected companies 

 
Global Fundraising Campaign Bootcamp:

The 15 selected companies will have exclusive access to a 5-day intensive course on global fundraising, valued at €2,000, to increase their chances of success in closing funding rounds.

Virtual Class:

  1. Feb 24th 5PM CET:  Nuts and bolts of preparing and executing a global partnering campaign and road show.
  2. Feb 27th 5PM CET : Tagline and elevator pitch.
  3. Mar 3rd 5PM CET:  Breakout session 1.
  4. Mar 6th 5PM CET:  Executive summary, one page data sheet, pitch deck.
  5. Mar 10th 5PM CET : Breakout session 2.
  6. Mar 13th 5PM CET:  Maximizing your pitch, poster preparation and navigating the partnering system, using a CRM.

March 31 : Half-day education course 9AM-1PM 

This intensive bootcamp, delivered by Life Science Nation, will provide you with essential tools to connect with top investors in the sector and secure the necessary funding.

Advantages of participating in the IPC

  • Opportunity to pitch in front of a panel of pre-selected investor judges and expert investors. 
  • 6 minutes of presentation and 7 minutes of questions and answers. 
  • Session moderators will strictly enforce these time limits to ensure a fair and equitable opportunity for all participants. 
  • Participants will be assigned to a live presentation session and Q&A based on their sector or technology.

 

IPC Prizes

All registered attendees at RESI will receive 5 "RESI Cash" vouchers when they register for the conference. All attendees will be able to use "RESI Cash" to "invest" in the IPC finalist companies they find most attractive. The 3 companies with the most "RESI Cash" invested will be announced during the IPC awards ceremony and will receive the following:

  • 1st place (valued at €12,000): Free entry to 3 RESI events* of their choice (up to 2 entries per event).
  • 2nd place (valued at €8,000): Free entry to 2 RESI events* of their choice (up to 2 entries per event).
  • 3rd place (valued at €4,000): Free entry to 1 RESI event* of their choice (up to 2 entries per event).

*Free entries must be redeemed within one calendar year after finishing in the top three.

*For more information, contact Adrià Gómez (agomez@biocat.cat)

More information IPC

Sessions of interest

Round Table

Healthtech Market Access Panel Discussion

To explore the challenges and strategies in achieving market access for healthtech innovations, focusing on regulatory hurdles, coverage, coding, reimbursement and adoption pathways, and the role of data and digital tools in healthcare.

 

01/04/2025

11:00 AM - 11:50 AM

Hotel InterContinental Barcelona

 Organized by Biocat 

 

Moderator:

  • Carmen Ríos, CEO Doctomatic

 

Speakers:

  • Ramon Maspons, Chief Health Innovation Strategist.  Ministry of Health, Government of Catalonia.
  • Meike Bomhof, VP Market Access of Avania.
  • Ana Maiques, CEO Neuroelectrics.
  • Francisco Rodríguez, Medical Device Manager and Lead Auditor of Asphalion.

 

Institutional Reception and IPC Award Ceremony


01/04/2025

5 PM -7 PM

Hotel InterContinental Barcelona (Terrace Garden)

5 PM Welcome from Dennis Ford, Founder and CEO of LSN

5:10 PM Speech by Xavier Mayo, Head of the Barcelona Investment Office – BIO, Barcelona City Council

5:20 PM Presentation of the Innovator’s Pitch Challenge Awards by Dennis Ford, Xavier Mayo and Robert Fabregat (General Director of Biocat)

6 PM Cocktail Networking.

List of investors

Inversor Country    Continent
Global Emerging Markets (GEM)United StatesAmerica
Technomark Life SciencesUnited StatesAmerica
Pharma Capital PartnersUnited StatesAmerica
AZCA, IncUnited StatesAmerica
Plug and Play VenturesUnited StatesAmerica
Shimadzu CorporationJapanAsia
Asymmetry VenturesUnited StatesAmerica
Northlea PartnersUnited StatesAmerica
Mid Atlantic Bio AngelsUnited StatesAmerica
Aphelion Capital, LLCUnited StatesAmerica
Life Science AngelsUnited StatesAmerica
Myeloma Investment FundUnited StatesAmerica
Evidence VenturesUnited StatesAmerica
Taiho VenturesUnited StatesAmerica
LongGameUnited StatesAmerica
Transatlantic Life Science VentureUnited StatesAmerica
NovartisUnited StatesAmerica
FoxHill Asset ManagementUnited StatesAmerica
Atlas Capital Ventures, LLCUnited StatesAmerica
NYBC VenturesUnited StatesAmerica
Evio Venture CapitalUnited StatesAmerica
Meritage Technologies Inc.United StatesAmerica
Curie.BioUnited StatesAmerica
BioMap Inc.United StatesAmerica
Coho DeeptechUnited StatesAmerica
GaingelsUnited StatesAmerica
Angel InvestorUnited StatesAmerica
Thielsen CapitalUnited StatesAmerica
Accequa ABUnited StatesAmerica
PROMERCA Family OfficeUnited StatesAmerica
InVivium CapitalUnited StatesAmerica
Pappas CapitalUnited StatesAmerica
MEDA VenturesUnited StatesAmerica
Springhood VenturesUnited StatesAmerica
1004 Venture PartnersUnited StatesAmerica
Oncology VenturesUnited StatesAmerica
Individual AngelUnited StatesAmerica
NVIDIA CorporationUnited StatesAmerica
Ajinomoto Corporate Venture CapitalUnited StatesAmerica
Fast Track InitiativeJapanAsia
General InceptionUnited StatesAmerica
Mass Medical AngelsUnited StatesAmerica
Rising PharmaceuticalsUnited StatesAmerica
Aditum BioUnited StatesAmerica
BOLD Longevity Growth FundUnited StatesAmerica
Voloridge HealthUnited StatesAmerica
TransAtlantic Angel ConferenceUnited StatesAmerica
Kicker VenturesUnited StatesAmerica
Global Emerging Markets (GEM)United StatesAmerica
Voloridge HealthUnited StatesAmerica
Meiji Pharma USAUnited StatesAmerica
CPI EnterprisesUnited KingdomEurope
RYSEUnited KingdomEurope
Global Bio Fund (Jaya Ventures)United KingdomEurope
Kerna VenturesUnited KingdomEurope
Manta Ray VenturesUnited KingdomEurope
GGS AssociatesUnited KingdomEurope
NG BioUnited KingdomEurope
Claret Capital PartnersUnited KingdomEurope
Deep Science VenturesUnited KingdomEurope
O2h VenturesUnited KingdomEurope
IPF PartnersSwitzerlandEurope
Endeavor Venture Fund & Venture StudioSwitzerlandEurope
Breslin AGSwitzerlandEurope
RedalpineSwitzerlandEurope
Debiopharm International S.A.SwitzerlandEurope
Convergence Partners AGSwitzerlandEurope
Ferring PharmaceuticalsSwitzerlandEurope
Aliath BioventuresSpainEurope
Capital CellSpainEurope
Ysios CapitalSpainEurope
Clave CapitalSpainEurope
Inveready Asset ManagementSpainEurope
Invivo PartnersSpainEurope
Plutus Advisors LLCSpainEurope
We Venture CapitalSpainEurope
Namarel VenturesSpainEurope
BeAble CapitalSpainEurope
LifeLink VenturesSpainEurope
GrifolsSpainEurope
Ship2B VenturesSpainEurope
Montana Impact FundSpainEurope
Nara CapitalSpainEurope
Inveniam GroupSpainEurope
Columbus Venture PartnersSpainEurope
Inveniam GroupSpainEurope
Montana Impact FundSpainEurope
CRB InverbioSpainEurope
Inveready Asset ManagementSpainEurope
Ship2B VenturesSpainEurope
Criteria Bio VenturesSpainEurope
Inveready Asset ManagementSpainEurope
Bio & Tech Smart Capital - Noso CapitalSpainEurope
Montana Impact FundSpainEurope
University of Navarra (Universidad de Navarra)SpainEurope
Verge Health Tech FundSingaporeAsia
LAFANASaudi ArabiaAsia
CS VenturesNew ZealandOceania
dsm-firmenich VenturesNetherlandsEurope
Lumo LabsNetherlandsEurope
M VenturesNetherlandsEurope
Brightlands Venture PartnersNetherlandsEurope
Swanbridge CapitalNetherlandsEurope
Caju Venture PartnersNetherlandsEurope
EQT Life SciencesNetherlandsEurope
Brightlands Venture PartnersNetherlandsEurope
NLC Health VenturesNetherlandsEurope
Ikigai VenturesLuxembourgEurope
LongeVCLatviaEuropa
CelltrionRepublic of KoreaAsia
Asahi Intecc USA IncJapanAsia
Maruho Co., Ltd.JapanAsia
EA Pharma Co., Ltd.JapanAsia
SantenJapanAsia
Asahi Kasei Pharma CorporationJapanAsia
Sumitomo Pharma Co., Ltd.JapanAsia
FUJIFILM CorporationJapanAsia
JT PharmaJapanAsia
Medical Incubator Japan (MIJ)JapanAsia
Panakes PartnersItalyEurope
Angelini VenturesItalyEurope
Digital Networks PLCItalyEurope
NovaterraItalyEurope
ChiesiItalyEurope
Women Angels for SteamItalyEurope
XGEN VentureItalyEurope
AurorA ScienceItalyEurope
Corundum NeuroscienceIsraelAsia
Arkin BioIsraelAsia
Seroba Life SciencesIrelandEurope
Kernel CapitalIrelandEurope
BioIdeationsIndiaAsia
FastVenturesHungaryEurope
Summer Atlantic CapitalChinaAsia
Apollo Health VenturesGermanyEurope
ekwithreeGermanyEurope
RV Invest GmbHGermanyEurope
Peppermint Venture PartnersGermanyEurope
NeuraxpharmGermanyEurope
AdBio PartnersFranceEurope
Sofinnova PartnersFranceEurope
M2CareFranceEurope
Andera PartnersFranceEurope
InnovestorFinlandEurope
Look AI VenturesCzech RepublicEurope
Shanda VenturesChinaAsia
Gaorong CapitalChinaAsia
Autobio Venture CapitalChinaAsia
IHM-GBAChinaAsia
Launchit VenturesCanadaAmerica
Desire VenturesCanadaAmerica
Leva CapitalCanadaAmerica
Quatá Confidence CapitalBrazilAmerica
Heran PartnersBelgiumEurope
TCD CapitalBelgiumEurope

RESI Europe 2024 recap

Organized by:

Co-organized by:

Sign up for our newsletters

Stay up-to-date on the latest news, events and trends in the BioRegion.